Health

Results: 1-12 of 8661

Implantica announces publication of a new health economics study showing RefluxStop®'s superior cost-effectiveness in the treatment of GERD in the Italian Healthcare System

PR Newswire associated0

The Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund

PR Newswire associated0

Leo Cancer Care Secures CE Mark for Marie®, Advancing Upright Radiotherapy in Europe

PR Newswire associated0

NCCN Affirms Commitment to Cancer-Related Distress Resources Worldwide During Mental Health Awareness Month

PR Newswire associated0

Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

AHF, the world’s largest HIV/AIDS organization, is proud to announce a historic new milestone: 3 million lives in care in 50 AHF countries across the globe. The achievement reflects AHF’s global commitment to HIV prevention, care, and treatment—and comes as the organization marks the 25th anniversary of its first global programs, launched in South Africa and Uganda in early 2001, and approaches the 40th anniversary of its founding in Los Angeles. Billboards featuring this art will go up in several key AHF U.S. markets and countries worldwide.

3 Million Lives in Care! AHF Hits Historic New Global Milestone

BeOne Medicines' One Save Changes Everything campaign uses soccer as a lens to recognize the scientific, clinical, and human moments that matter in cancer care.

BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard

Maria Paola Chiesi is appointed Chair of Chiesi Board of Directors, the first woman in this role; aims to reinforce sustainability as an integral and enduring pillar of the Group’s strategy

Chiesi Group Announces New Chair and Vice Chair

Statement from Professor Neil Greenberg, the Society of Occupational Medicine on the fit note reforms

BioArctic Interim Report for the period January - March 2026

Implantica submits final response to FDA in the PMA application for RefluxStop® for U.S. market approval

Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder